Related Experiment Video
Updated: Jun 22, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Advances in percutaneous coronary intervention
1Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY 10022, USA.
Insights
Percutaneous coronary intervention (PCI) has evolved from simple balloon angioplasty to a vital treatment for coronary artery disease. Advances like drug-eluting stents and improved medications enhance PCI
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) evolved from balloon angioplasty for coronary stenoses.
- PCI is crucial for managing coronary artery disease (CAD), improving quality of life, and saving lives in acute scenarios.
Purpose of the Study:
- To review the evolution and current role of PCI in managing coronary artery disease.
- To highlight advancements in PCI safety and efficacy.
Main Methods:
- Review of historical development of PCI techniques and devices.
- Analysis of adjunctive pharmacotherapy, including antithrombotic and antiplatelet agents.
- Evaluation of the impact of drug-eluting stents and next-generation technologies.
Main Results:
- PCI has expanded its applicability to most CAD patients.
- Adjunctive pharmacotherapy significantly enhances PCI safety.
- Drug-eluting stents have improved long-term PCI durability.
Conclusions:
- PCI is a cornerstone in managing coronary artery disease, supported by extensive clinical trial evidence.
- Ongoing advancements in stents and pharmacologic agents continue to improve PCI safety and efficacy.
Abstract:
Initially developed more than 30 years ago as simple balloon-based dilatation for focal coronary stenoses, the introduction of the coronary stent allowed percutaneous coronary intervention (PCI) to be applied to most patients with coronary artery disease. PCI improves quality of life by relieving angina in patients with stable coronary artery disease and can be life saving in patients with extensive ischemia and acute coronary syndromes. The safety of the PCI procedure has been enhanced significantly by the appropriate application of adjunctive pharmacotherapy, most importantly antithrombotic and antiplatelet agents. The advent of drug-eluting stents has significantly prolonged the durability of PCI. The safety and efficacy of PCI continue to evolve with the development of next-generation stents and safer and improved pharmacologic agents. An extensive evidence base of randomized clinical trials has established PCI as an important strategy with a pivotal role in the management of patients with coronary artery disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Angina IV: Management
Acute Coronary Syndrome I: Introduction

